The humble aspirin may soon have a new role. Scientists from The City College of New York have developed a new aspirin compound that has great promise to be not only an extremely potent cancer-fighter, but even safer than the classic medicine cabinet staple.
The new designer aspirin curbed the growth of 11 different types of human cancer cells in culture without harming normal cells, reported a team from the Sophie Davis School of Biomedical Education of The City College of New York in a paper published this month in the journal ACS Medicinal Chemistry Letters. The cancers controlled included colon, pancreatic, lung, prostate, breast, and leukaemia. ‘The key components of this new compound are that it is very, very potent and yet it has minimal toxicity to the cells,’ said Associate Professor Khosrow Kashfi, the principal investigator.
The aspirin compound also shrank human colon cancer tumours by 85 percent in live animals, again without adverse effects, according to a second paper in press by the City College researchers and colleague Kenneth Olson of Indiana University School of Medicine, South Bend. ‘If what we have seen in animals can be translated to humans,’ said Professor Kashfi, ‘it could be used in conjunction with other drugs to shrink tumours before chemotherapy or surgery.’
Long the go-to drug for minor aches and pains, aspirin and other so-called non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and naproxen, are known primarily for their ability to calm inflammation. Studies in the 1980
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:42:452020-08-26 14:43:02Could a NOSH-Aspirin-a-Day keep cancer away?
Early detection of melanoma, the most aggressive skin cancer, is critical because melanoma will spread rapidly throughout the body. Now, University of Missouri researchers are one step closer to melanoma cancer detection at the cellular level, long before tumours have a chance to form. Commercial production of a device that measures melanoma using photoacoustics, or laser-induced ultrasound, will soon be available to scientists and academia for cancer studies. The commercial device also will be tested in clinical trials to provide the data required to obtain U.S. Food and Drug Administration approval for early diagnosis of metastatic melanoma and other cancers.
‘Using a small blood sample, our device and method will provide an earlier diagnosis for aggressive melanoma cancers,’ said John Viator, associate professor of biomedical engineering and dermatology in the Christopher S. Bond Life Sciences Center. ‘We compare the detection method to watching an eight-lane highway full of white compact cars. In our tests, the cancer cells look like a black 18-wheeler.’
Currently, physicians use CT or MRI scans for melanoma cancer detection, costing thousands of dollars. Viator
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:42:452020-08-26 14:43:09Photoacoustic device finds cancer cells before they become tumours
Among women with gestational diabetes mellitus, referral to a telephone-based nurse management program was associated with lower risk of high baby birth weight and increased postpartum glucose testing, according to Kaiser Permanente researchers.
Investigators for the Kaiser Permanente Northern California Division of Research examined the associations between referral to telephone-based nurse consultation and outcomes in 12 Kaiser Permanente medical centres with variation in the percent of patients referred to telephonic nurse management.
‘Compared with women from Kaiser Permanente medical centres where the annual proportions of referral to nurse management at the Kaiser Permanente Regional Perinatal Service Center was less than 30 percent, women who delivered in medical centres with an annual referral proportion of greater than 70 percent were less likely to have a high birth weight infant without increasing the risk or having a low birth weight infant,’ said Assiamira Ferrara, MD, PhD, a research scientist with the Kaiser Permanente Northern California Division of Research and the lead author of the study. ‘In addition, they were more likely to have postpartum glucose testing, which leads to earlier identification and management of postpartum glucose intolerance or diabetes.’
Investigators used data from the Kaiser Permanente Northern California GDM registry to identify women who had pregnancy complicated by GDM from 1997 through 2006. They restricted their cohort to women with GDM according to the National Diabetes Data Group criteria. During the study period, 96 percent of all pregnant women without pre-existing diabetes who delivered an infant were screened for GDM. Researchers excluded women who delivered multiple births due to their increased risk of perinatal complications. Overall, researchers identified 11,435 women with GDM at the 12 medical centres, of whom 44.5 percent were referred to the perinatal service centre.
‘The Kaiser Permanente Regional Perinatal Service Center is a nurse-based management program for women with GDM that offers supplemental care via telephone counselling to women with high-risk pregnancies, including those complicated by GDM,’ explained co-author Monique Hedderson, PhD, a research scientist with the Kaiser Permanente Northern California Division of Research.
The program includes a call center with 32 registered nurses and two registered dieticians who offer phone counselling seven days a week and address glucose monitoring and control, diet and physical activity. Nurses are available 24 hours a day, seven days a week, while dieticians are available to patients during the week from 8 a.m. to 5 p.m. In addition to care provided by obstetricians, women referred to the centre receive one to two counselling calls per week to help them manage their blood glucose levels during pregnancy. The centre also sends a laboratory slip for postpartum glucose testing and a reminder telephone call if the screening test was not performed.
EurekAlert
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:42:452020-08-26 14:42:48Phone contact with nurses linked with better outcomes for women with gestational diabetes
Women undergoing treatment for breast cancer might fight off distressing side effects and improve psychological well-being by staying off the couch. According to the University of Miami (UM) study, women who are physically active during treatment have less depression and an enhanced quality of life and report less debilitating fatigue.
‘Women who are physically active may also have more confidence in their own ability to continue with family-related, household, work-related, or social activities, which bring meaning and satisfaction to their lives,’ says Jamie M. Stagl, M.S., doctoral student in Clinical Health Psychology in the College of Arts and Sciences at UM and lead author of the study. ‘This may lead to appraisals of lower fatigue, heightened quality of life, and less depression.’
UM researchers studied the reported physical activity of 240 women recently diagnosed with non-metastatic breast cancer and recruited from four to 10 weeks post-surgery. Participants attended a 10-week, group-based Cognitive Behavioral Stress Management (CBSM) intervention, or a one-day psychoeducation ‘self-help’ comparison group. In addition, researchers monitored the women’s reported physical activity levels.
While these researchers have previously shown that stress management improves breast cancer treatment, the current study reveals that there are additional benefits for women who are also physically active through treatment.
‘Women who increased the amount of time they spent being physically active between the weeks after surgery and their adjuvant therapy had less ‘fatigue disruption’
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:42:452020-08-26 14:42:57Exercise improves quality of life during breast cancer treatment
The market for electronic health technology or eHealth is growing fast in the European Union. This is largely due to the unstoppable demand for mobile health devices which help patients to monitor their health, communicate with their doctors and store medical records. Meanwhile, the EU institutions are trying to speed up legislation to boost growth in the sector.
The demand for such services is expected to grow exponentially as the ageing baby boomers put increasing pressure on healthcare systems. It is estimated that nearly 30% of Europeans will be over 65 by the year 2050.
Many phone and TV companies across Europe are currently developing technologies to check your blood pressure and sugar level, and will remind you to take your medicine. This information is relayed over cable and satellite networks to users. KPN offers its diabeticStation in the Netherlands, Telecom Italia has the MyDoctor@home service, and Orange has a medication reminder solution. These services help to reduce the cost and time patients spend in hospital or at the doctor. In Belgium, Belgacom is testing a project for people with heart conditions, while Portugal Telecom and Deutsche Telekom have services for disabled people.
The eHealth industry has a critical role to play in the European Union
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:42:452020-08-26 14:43:04Growth of eHealth boosted by mobile health devices
A new electronic medical record tool that tallies patients’ previous radiation exposure from CT scans helps reduce potentially unnecessary use of the tests among emergency room patients with abdominal pain, according to a study from researchers at the Perelman School of Medicine at the University of Pennsylvania. The new study shows that when the tool is in use, patients are 10 percent less likely to undergo a CT scan, without increasing the number of patients who are admitted to the hospital.
Abdominal pain is the most common reason why people seek care in emergency rooms in the United States, accounting for 10 million visits each year. But the symptoms may be caused by myriad problems, from those that can be fixed with a single dose of an over-the-counter drug to those that could prove life-threatening within hours: from a bout of GI distress to an ectopic pregnancy; from constipation to an appendix about to burst; from a hernia to signs of a chronic condition like Crohn’s disease.
This complex diagnostic face-off plays a huge role in why emergency physicians tend to lean heavily on tests like CT scans, even though they expose patients to radiation and there are few clear guidelines on which patients should get them. Since the mid-1990s, the use of CT scans to diagnose ER patients has surged, increasing ten-fold. Today, 14 percent of all emergency room patients get scanned
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:42:452020-08-26 14:42:51Electronic medical record tool cuts down on unnecessary CT scans in emergency room
One in eight women in the United States will develop breast cancer. Of those, many will undergo surgery to remove the tumour and will require some kind of breast reconstruction afterward, often involving implants. Cancer is an elusive target, though, and malignant cells return for as many as one-fifth of women originally diagnosed, according to the American Cancer Society.
Would it be possible to engineer implant materials that might drive down that rate of relapse? Brown University biomedical scientists report some promising advances. The team has created an implant with a ‘bed-of-nails’ surface at the nanoscale (dimensions one-billionth of a meter, or 1/50,000th the width of a human hair) that deters cancer cells from dwelling and thriving. Made out of a common federally approved polymer, the implant is the first of its kind, based on a review of the literature, with modifications at the nanoscale that cause a reduction in the blood-vessel architecture on which breast cancer tumours depend
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:42:452020-08-26 14:42:59?Bed-of-nails? breast implant deters cancer cells
Robotics experts at UC Santa Cruz and the University of Washington (UW) have completed a set of seven advanced robotic surgery systems for use by major medical research laboratories throughout the United States. After a round of final tests, five of the systems will be shipped to medical robotics researchers at Harvard University, Johns Hopkins University, University of Nebraska, UC Berkeley, and UCLA, while the other two systems will remain at UC Santa Cruz and UW.
‘We decided to follow an open-source model, because if all of these labs have a common research platform for doing robotic surgery, the whole field will be able to advance more quickly,’ said Jacob Rosen, associate professor of computer engineering in the Baskin School of Engineering at UCSC and principal investigator on the project.
Rosen and Blake Hannaford, director of the UW Biorobotics Laboratory, lead the research groups that developed the Raven II robotic surgery system and its predecessor, Raven I. A grant from the National Science Foundation funded their work to create seven identical Raven II systems. Hannaford said the systems will be shipped out from UW by the end of January. After they are delivered and installed, all seven systems will be networked together over the Internet for collaborative experiments.
Robotic surgery has the potential to enable new surgical procedures that are less invasive than existing techniques. For some procedures, such as prostate surgery, the use of surgical robots is already standard practice. In addition, telesurgery, in which the surgeon operates a robotic system from a remote location, offers the potential to provide better access to expert care in remote areas and the developing world. Having a network of laboratories working on a common platform will make it easier for researchers to share software, replicate experiments, and collaborate in other ways.
Even though it meant giving competing laboratories the tools that had taken them years to develop, Rosen and Hannaford decided to share the Raven II because it seemed like the best way to move the field forward. ‘These are the leading labs in the nation in the field of surgical robotics, and with everyone working on the same platform we can more easily share new developments and innovations,’ Hannaford said.
According to Rosen, most research on surgical robotics in the United States has focused on developing new software for various commercially available robotic systems. ‘Academic researchers have had limited access to these proprietary systems. We are changing that by providing high-quality hardware developed within academia. Each lab will start with an identical, fully-operational system, but they can change the hardware and software and share new developments and algorithms, while retaining intellectual property rights for their own innovations,’ Rosen said.
The Raven II includes a surgical robot with two robotic arms, a camera for viewing the operational field, and a surgeon-interface system for remote operation of the robot. The system is powerful and precise enough to support research on advanced robotic surgery techniques, including online telesurgery.
University of California – Santa Cruz
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:42:452020-08-26 14:43:07‘Open-source’ robotic surgery platform going to top medical research labs
Nursing homes that foster an environment in which workers feel they are valued contributors to a team of caregivers provide better care to their residents. That is the conclusion of a study.
‘We know from other fields of medicine that teamwork
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:42:452020-08-26 14:42:46Study links teamwork, communication with quality of nursing home care
Migraine pain sits at the upper end of the typical pain scale
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:42:452020-08-26 14:42:54Technology eases migraine pain in the deep brain
We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.
Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.
Essential Website Cookies
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.
We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.
We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.
.
Google Analytics Cookies
These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.
If you do not want us to track your visit to our site, you can disable this in your browser here:
.
Other external services
We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page
Google Webfont Settings:
Google Maps Settings:
Google reCaptcha settings:
Vimeo and Youtube videos embedding:
.
Privacy Beleid
U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.